

Product description
miscellaneous:ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2).,sequence caution:Contaminating sequence. Sequence of unknown origin in the N-terminal part.,
Source
Rabbit
Applications
WB,ELISA
Reactivity
Human,Mouse
Dilution
WB: 1/500 - 1/2000. ELISA: 1/5000. Not yet tested in other applications.
Storage
-20°C/1 year
Specificity
ALS2CR13 Polyclonal Antibody detects endogenous levels of ALS2CR13 protein.
Source/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
The antiserum was produced against synthesized peptide derived from human ALS2CR13. AA range:411-460
Uniprot No
Q6P1L5
Alternative names
FAM117B; ALS2CR13; Protein FAM117B; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein
Form
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Background
miscellaneous:ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2).,sequence caution:Contaminating sequence. Sequence of unknown origin in the N-terminal part.,
Other
Gene_name: FAM117B ; Protein_name: Protein FAM117B; Expression: Human salivary gland,Kidney,Skin,
Mol.Wt (Da)
60 kD
Concentration
1 mg/ml
-
Promotion
-
Order
-
Online message
-
Help center